Legend Biotech (LEGN) Tax Provisions (2019 - 2025)
Legend Biotech (LEGN) posted Tax Provisions of -$11.2 million for Q4 2025, down 1718.18% on a QoQ basis from -$616000.0 in Q3 2025, and up 21.13% year-over-year from -$9.2 million in Q4 2024.
Legend Biotech (LEGN) has 7 years of Tax Provisions data on file, last reported at -$11.2 million in Q4 2025.
- In Q4 2025, Tax Provisions rose 21.13% year-over-year to -$11.2 million; the TTM figure through Dec 2025 stood at -$14.2 million (up 24.82% YoY), while the FY2025 annual figure was -$14.2 million, up 24.87% from the prior year.
- Tax Provisions fell to -$11.2 million in Q4 2025, from -$616000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $288000.0 in Q3 2023 and bottomed at -$14.2 million in Q4 2024.
- A 5-year average of -$2.0 million and a median of -$163000.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions surged 289.47% — and 2024, when it tumbled 712236.41%.
- Year by year, Tax Provisions stood at -$3.6 million in 2021, then soared by 95.77% to -$153000.0 in 2022, then soared by 101.3% to $1994.0 in 2023, then tumbled by 712236.41% to -$14.2 million in 2024, then increased by 21.13% to -$11.2 million in 2025.
- The last three Tax Provisions figures came in at -$11.2 million (Q4 2025), -$616000.0 (Q3 2025), and -$582000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.20 Mn |
| Sep 30, 2025 | -616,000.00 |
| Jun 30, 2025 | -582,000.00 |
| Mar 31, 2025 | -1.79 Mn |
| Dec 31, 2024 | -14.20 Mn |
| Sep 30, 2024 | -4.44 Mn |
| Jun 30, 2024 | -226,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 1,994.00 |
| Sep 30, 2023 | 288,000.00 |
| Jun 30, 2023 | -290,000.00 |
| Mar 31, 2023 | -128,000.00 |
| Dec 31, 2022 | -153,000.00 |
| Sep 30, 2022 | -152,000.00 |
| Jun 30, 2022 | -157,000.00 |
| Mar 31, 2022 | -163,000.00 |
| Dec 31, 2021 | -3.61 Mn |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | 4,082.00 |
| Dec 31, 2020 | -72,000.00 |
| Sep 30, 2020 | 508,000.00 |
| Dec 31, 2019 | -2.26 Mn |
| Jun 30, 2019 | -336,000.00 |